Abstract Details
|
Anne C. Van Cott, MD, FAAN
(VA Pittsburgh Healthcare System/University of Pittsburgh)
PRESENTER |
Dr. Van Cott has nothing to disclose. |
| No disclosure on file | |
| Kathryn Tortorice, Pharm D, BCPS (US Department of Veterans Affairs) | No disclosure on file |
| Mary Jo Pugh, PhD, RN, FAAN | The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi. |
| Barry E. Gidal, PhD | Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science . |
| No disclosure on file | |
| No disclosure on file |